News Focus
News Focus
Replies to #3367 on Biotech Values
icon url

DewDiligence

08/27/04 10:36 AM

#3370 RE: rkrw #3367

I understand your reasoning, but I wonder if you really believe it yourself. If it turns out that today’s panel does not back Macugen wholeheartedly, I fully expect the cheerleaders on the Yahoo board to contradict their prior statements and proclaim that such an outcome is hugely positive for GENR.

According to your analysis, however, a thumbs-down or a half-hearted endorsement of Macugen would have be bad for GENR. Will you truthfully find GENR less appealing as an investment if such an outcome should come to pass?

P.S. Bill Cadger does not immediately ring a bell, but it’s been a more than a decade since I was active in tournament circles and my LT memory ain’t what it used to be :-)